Home Merck Resolves Securities Class-Action Lawsuits Related to the ENHANCE Trial
 

Keywords :   


Merck Resolves Securities Class-Action Lawsuits Related to the ENHANCE Trial

2013-02-14 14:00:00| Merck.com - Corporate News

Dateline City:  WHITEHOUSE STATION, N.J. The Company Records $493 Million Charge Reducing 2012 GAAP Results WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck, known as MSD outside the United States and Canada, announced today that it has reached an agreement in principle with plaintiffs to resolve two federal securities class-action lawsuits. The suits are pending in the U.S. District Court for the District of New Jersey against Merck, Schering-Plough Corporation and certain of their current and former officers and directors. Language:  English Contact HTML:  MerckMedia Contacts:Ron Rogers, 908-423-6449Steve Cragle, 908-423-3461ORInvestor Contacts:Carol Ferguson, 908-423-4465Justin Holko, 908-423-5088 Ticker Slug:  Ticker: MRK Exchange: NYSE read more

Tags: related trial enhance securities

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
24.115 2 PG
24.11215103TW 17svtw
24.11 Switch light
24.11Dr.SLUMP 19
24.11layover LP
24.11PING i230 6W 5
24.11BTS CD
24.11HG 56
More »